Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor ...

Using CD22/CD19 CAR T-cell therapy followed by autologous stem cell transplant (ASCT) showed promising results in patients ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

Cancer is a multifactorial chronic disease, with its pathogenesis and progression influenced by various factors. The immune ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

By Tarun Sai Lomte Researchers engineered an injectable silica-based scaffold that trains the immune system to attack S.

LUND, SE / ACCESS Newswire / December 1, 2025 / Alligator Bioscience (STO:ATORX) today announced the publication of a peer-reviewed article in Nature communications, reporting data from the REACtiVe-2 ...